| Erbel, Christian |
NCT05110079: Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Followup |
|
|
| Recruiting | N/A | 75 | Europe | ByCross Atherectomy and Thrombectomy | Taryag Medical Ltd. | Peripheral Arterial Disease | 12/22 | 03/23 | | |
| Recruiting | N/A | 300 | Europe, US | ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc. | Inari Medical | Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome | 06/25 | 10/25 | | |
NCT04907240: Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry |
|
|
| Recruiting | N/A | 614 | Europe | GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX) | W.L.Gore & Associates | Peripheral Artery Disease, Popliteal Aneurysm, Hemodialysis Access, Visceral Artery Aneurysms, Trauma Injury | 10/26 | 10/35 | | |
LIMES, NCT04772300: Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease |
|
|
| Recruiting | N/A | 230 | Europe | Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter, Percutaneous Transluminal Angioplasty (PTA) with non-coated balloon catheter (POBA) | Jena University Hospital, Concept Medical Inc., Vascuscience, CoreLab Black Forest, Center for Clinical Studies, University Hospital Jena | Peripheral Artery Disease | 12/27 | 09/28 | | |
